Trait Closes C$12.3M Private Placement to Fund Cannabis Innovations
Ryan Allway
September 30th, 2018
News
Trait Biosciences Inc. (“Trait” or the “Company“), a bio-technology leader in the cannabis industry, today announced that it has closed an over-subscribed private placement seed financing (the “Financing“) totalling CAD$12.3 million.
Trait is developing critical technologies that offer breakthroughs for consumers and producers in the cannabis industry, with an internationally recognized science team led by Dr. Richard Sayre. Dr. Sayre has been recognized by Nature as one of the “top five crop researchers who could change the world.”
The funds will be invested in continuing research and patent creation, as well as the construction of a second research laboratory in Toronto, Canada.
Trait’s Consumer Division is developing enhanced cannabinoids to have improved taste, scent, onset, bioavailability and stability. It also has a proprietary process for generating water-soluble cannabinoids that does not rely on nanotechnology, solving a major barrier for cannabis beverages and edibles.
Trait’s Producer Division is working with ultrahigh yield “Super Producer” cannabis plants that can generate dramatically greater yields and RNAi plant protection technologies that reduce the accumulation of toxins in cannabis plants without the need for pesticides or fungicides.
Three Executive Hires
These transformative technologies will be harnessed and brought to market by Trait’s newly appointed executive team, three proven leaders in the cannabis industry: Joseph del Moral, Hannan Fleiman and Ronan Levy. Mr. del Moral is taking over the role of CEO from Kimberly Harrison, one of Trait’s co-founders, who is moving into the newly created role of Chief Development Officer. Mr. Fleiman is assuming the position of President and Mr. Levy as Chief Strategy Officer. Mr. del Moral and Mr. Levy have also joined Trait’s board of directors.
Prior to Trait, the three new executives founded Canadian Cannabis Clinics and CanvasRx Inc. CanvasRx was acquired in 2016 by Aurora Cannabis Inc. Since then, Messrs. del Moral, Fleiman and Levy have been active investors and advisors in the industry, including Aurora.
“We are delighted that Joseph, Hannan, and Ronan have joined the Trait executive team,” said Michael Harrison, Trait’s Chairman. “It is a strong endorsement for what our scientific team has achieved since we launched a year ago. With the team’s vision, experience, and determination — supported by the funds from our recently completed financing — we are confident that Trait will become a dominant player and creative force in the cannabis industry.”
“It is exciting to be part of Trait,” said Mr. del Moral. “The technologies Dr. Sayre’s science team has developed are game-changing and immediately relevant. From the first efficient and scalable platform to produce water-soluble, full-profile cannabinoids, to the yield-enhancing “Super Producer” technology combined with its RNAi plant protection technology — all backed by a robust patent portfolio — Trait is going to play a significant role in the development of the cannabis industry.”
“Over the last two years, we’ve had the opportunity to vet hundreds of cannabis companies and technologies,” said Mr. Levy. “For us to be joining the executive team at Trait and also to be leading the current investment round, speaks volumes to the profound and immediate impact we expect Trait to have on the industry.”
Trait Closes CAD$12.3 Million Seed Financing
Trait also announced today that it closed a CAD$12.3 million private placement seed financing.
In addition to the incoming executive team, which led the financing, investors in the round include Green Acre Capital, CannaIncome Fund, and senior executives from many of Canada’s largest licensed producers. Proceeds from the financing will be used, amongst other things, to build a research facility in the Greater Toronto Area and grow Trait’s science team in Canada.
About Trait
With a team of internationally recognized scientists who are applying best-in-class technology and agricultural science, Toronto-based Trait is an emerging biotechnology leader in the cannabis industry. Its Consumer Division is developing technologies to create enhanced cannabinoids that have improved taste, scent, onset, bioavailability and stability, including a process for generating water-soluble cannabinoids that does not rely on nanotechnology. Trait’s Producer Division is developing technologies to increase yields and plant safety, including its ultrahigh yield “Super Producer” plants that can generate dramatically greater yields than other plants, and its RNAi crop protection platform, which reduces the accumulation of toxins in cannabis without the need for pesticides or fungicides, providing for more consistent and safer cannabis products.
Cautionary Statement on Forward-Looking Information
Certain information contained in this press release, including any information as to Trait Bioscience Inc.’s (the “Corporation”) strategy, projects, plans or future financial or operating performance, constitutes “forward-looking statements”. All statements, other than statements of historical fact, are forward-looking statements. The words “will”, “expect”, “continue”, “assess”, “anticipate” and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions that, while considered reasonable by the Corporation as at the date of this press release in light of each of management’s experience and perception of current conditions and expected developments, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information.
Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
First Foods Group, Inc. provides management services and funding options for emerging food brands and menu concepts, including a hemp-based chocolate line.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
